In addition, Pons et al. reported that genistein affected the efficacy of the anticancer therapies depending on the ERα/ERβ ratio in breast cancer cells (MCF-7, T47-D, MCF-7 overexpressing ERβ). The gene discussed is ESR2; the disease is breast carcinoma.